Abridge
The Engineering Manager for the GenAI Platform at Abridge is responsible for leading and developing a team focused on building the core infrastructure for LLM-driven workflows, retrieval systems, and evaluation processes. This role involves recruiting and mentoring engineers, collaborating with cross-functional teams, and guiding architectural discussions to shape the future of the Gen AI Platform. The manager will also ensure high software quality standards and compliance with industry regulations while operating in a fast-paced, high-growth environment.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2018
Abridge is a healthcare technology company that leverages generative AI to transform clinical documentation and patient-clinician conversations into actionable insights. Its innovative platform enables healthcare systems to create contextually aware, clinically useful, and billable AI-generated notes, enhancing the efficiency of clinicians, nurses, and revenue cycle teams. By seamlessly integrating into existing workflows, Abridge delivers measurable improvements in patient care and clinician satisfaction at scale. The company is recognized for its impactful contributions to the healthcare sector, receiving accolades for its cutting-edge solutions.
AI companies are leaning on partnerships for prior authorization
3 weeks ago
Inside the messy relationship between a medical records giant and healthcare's hottest AI startup
Sep 25, 2025
Abridge CTO talks Epic, Microsoft, and rebranding as ‘more than an AI scribe’
1 month ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Abridge.
Exclusive | Abridge, Whose AI App Takes Notes for Doctors, Valued at $5.3 Billion at Funding
Jun 24, 2025